GLP-1 medications like semaglutide work by mimicking the action of the GLP-1 hormone, a type of incretin hormone that is produced in the gut and helps stimulate insulin secretion after you eat
Recent studies have shown that patients on high-dose semaglutide can lose an average of 15% to 20% of their body weight, a level previously achievable only with bariatric surgery
Get the full picture on BPC-157
When auditing potential vendors, watch for these common red flags: 1) Absence of lot-specific COAs, or providing blurred COAs without visible batch numbers matching the delivered vial
It's designed specifically for this dosage tier
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing